NKGen Biotech, Inc.

Ownership Transactions Reported by 21 Insiders

Symbol
NKGN, NKGNW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
3001 Daimler St,, Santa Ana, CA

There are no Buy or Sell transactions made by insiders since 12/22/2023

NKGen Biotech, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sangwoo Park Director, Other*, 10%+ Owner $34.6M Dec 13, 2023
Graf Acquisition Partners IV LLC 10%+ Owner $8.02M Sep 29, 2023
Yong Man Kim CSO and CIO $93.4K Feb 12, 2024
Anatolio B. Cruz III Director $65.8K May 20, 2021
Jeanne Manischewitz Director $65.8K May 20, 2021
Edwin Rigaud Director $65.8K May 20, 2021
Alexandra Lebenthal Director $65.8K Jul 14, 2021
Gus Garcia Co-President, Director $4.94K May 25, 2021
Anthony A. Kuznik EVP, GC and Secretary May 20, 2021
Sterling Cross CFO and Treasurer May 11, 2022
Sabrina McKee EVP, Strategy May 20, 2021
Lewis Silberman Co-President, Director May 20, 2021
Anantha Ramamurti CFO and Treasurer May 20, 2021
Alana B. McNulty Director Sep 29, 2023
CFIC-2015 NV Family Investments, LLC 10%+ Owner Aug 12, 2024
James Graf Chief Financial Officer Dec 6, 2024
Paul Y. Song Chief Executive Officer Dec 6, 2024
Kathleen D. Scott Director Dec 6, 2024
Pierre Gagnon Chief Operating Officer Feb 12, 2024
Michael Klowden Director Dec 6, 2024
Marco Gottardis Director Jul 11, 2024

Recent Insider Transactions by Companies or Individuals for NKGen Biotech, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.